State Street Corp Rigel Pharmaceuticals Inc Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $173,288 - $242,913	154,722 Added 4.32%	3,734,799 $5.53 Million
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $54,998 - $119,163	76,387 Added 2.18%	3,580,077 $5.19 Million
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $21,961 - $28,529	-20,525 Reduced 0.58%	3,503,690 $3.78 Million
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.82 $87,427 - $142,069	78,060 Added 2.27%	3,524,215 $4.55 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $89,051 - $142,482	71,241 Added 2.11%	3,446,155 $4.55 Million
Q4 2022 Feb 14, 2023	SELL	$0.67 - $1.5 $337,111 - $754,728	-503,152 Reduced 12.97%	3,374,914 $5.06 Million
Q3 2022 Nov 15, 2022	SELL	$1.1 - $1.72 $22.1 Million - $34.5 Million	-20,067,502 Reduced 83.8%	3,878,066 $4.58 Million
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $11 Million - $52.4 Million	16,421,362 Added 218.25%	23,945,568 $27.1 Million
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $2.31 Million - $3.59 Million	-1,041,604 Reduced 12.16%	7,524,206 $22.5 Million
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $313,004 - $473,485	-132,629 Reduced 1.52%	8,565,810 $22.7 Million
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $6.98 Million - $8.97 Million	-1,993,485 Reduced 18.64%	8,698,439 $31.6 Million
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $5.64 Million - $8.28 Million	-1,824,801 Reduced 14.58%	10,691,924 $46.4 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $10.6 Million - $15.6 Million	3,154,221 Added 33.69%	12,516,725 $42.8 Million
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $1.75 Million - $2.78 Million	-743,841 Reduced 7.36%	9,362,504 $32.8 Million
Q3 2020 Nov 10, 2020	BUY	$1.78 - $4.13 $11.6 Million - $27 Million	6,542,643 Added 183.59%	10,106,345 $24.3 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $19,830 - $28,831	14,064 Added 0.4%	3,563,702 $6.52 Million
Q1 2020 May 11, 2020	BUY	$1.27 - $3.0 $4.51 Million - $10.6 Million	3,549,638 New	3,549,638 $5.54 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.32B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account